72
Views
28
CrossRef citations to date
0
Altmetric
Original Research

RACKI induces chemotherapy resistance in esophageal carcinoma by upregulating the PI3K/AKT pathway and Bcl-2 expression

, , , &
Pages 211-220 | Published online: 04 Jan 2018

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Di Huang, Xue Chen, Xuan Chen, Yan Qu, Yuanyuan Wang, Yafei Yang & Yufeng Cheng. (2020) WDR5 Promotes Proliferation and Correlates with Poor Prognosis in Oesophageal Squamous Cell Carcinoma. OncoTargets and Therapy 13, pages 10525-10534.
Read now
Ji-Xiang Cao & Yao Lu. (2019) Targeting CDC7 improves sensitivity to chemotherapy of esophageal squamous cell carcinoma. OncoTargets and Therapy 12, pages 63-74.
Read now

Articles from other publishers (26)

HY He, HZ Shan, SQ Li & RG Diao. (2023) Genistein attenuates renal ischemia-reperfusion injury via ADORA2A pathway. Human & Experimental Toxicology 42, pages 096032712311649.
Crossref
Xin Miao, Jinjing Hu, Changpeng Chai, Huan Tang, Zhenjie Zhao, Wei Luo, Wence Zhou & Hao Xu. (2022) Establishment and characterization of a new intrahepatic cholangiocarcinoma cell line derived from a Chinese patient. Cancer Cell International 22:1.
Crossref
Yiping Zhao, Xiaoxia Xia, Qiaomeng Wang, Debao Hu, Linlin Zhang, Xin Li, Xiangbin Ding, Hong Guo & Yiwen Guo. (2022) Myostatin Mutation Enhances Bovine Myogenic Differentiation through PI3K/AKT/mTOR Signalling via Removing DNA Methylation of RACK1. Cells 12:1, pages 59.
Crossref
Shanna Qian, Zhong Wei, Wanting Yang, Jinling Huang, Yinfeng Yang & Jinghui Wang. (2022) The role of BCL-2 family proteins in regulating apoptosis and cancer therapy. Frontiers in Oncology 12.
Crossref
Fang Wang, Juan Bai, Feng Li, Jing Liu, Yanli Wang, Ning Li, Yaqi Wang, Jin Xu, Wanbao Liu, Liting Xu & Lin Chen. (2022) Investigation of the mechanism of the anti-cancer effects of Astragalus propinquus Schischkin and Pinellia pedatisecta Schott (A&P) on melanoma via network pharmacology and experimental verification. Frontiers in Pharmacology 13.
Crossref
Marta Mascaraque-Checa, María Gallego-Rentero, Jimena Nicolás-Morala, Mikel Portillo-Esnaola, José M. Cuezva, Salvador González, Yolanda Gilaberte & Ángeles Juarranz. (2022) Metformin overcomes metabolic reprogramming-induced resistance of skin squamous cell carcinoma to photodynamic therapy. Molecular Metabolism 60, pages 101496.
Crossref
Li Wang, Xin Liu, Qian Kang, Chengyun Pan, Tianzhuo Zhang, Cheng Feng, Lu Chen, Sixi Wei & Jishi Wang. (2022) Nrf2 Overexpression Decreases Vincristine Chemotherapy Sensitivity Through the PI3K-AKT Pathway in Adult B-Cell Acute Lymphoblastic Leukemia. Frontiers in Oncology 12.
Crossref
Matheus Lohan-Codeço, Maria Luísa Barambo-Wagner, Luiz Eurico Nasciutti, Luis Felipe Ribeiro Pinto, Nathalia Meireles Da Costa & Antonio PalumboJrJr. (2022) Molecular mechanisms associated with chemoresistance in esophageal cancer. Cellular and Molecular Life Sciences 79:2.
Crossref
Yang Wang, Shi-Yang Shen, Lei Liu, Xiao-Dong Zhang, Dan-Yang Liu, Na Liu, Bing-Hua Liu & Lei Shen. (2022) Jolkinolide B inhibits proliferation or migration and promotes apoptosis of MCF-7 or BT-474 breast cancer cells by downregulating the PI3K-Akt pathway. Journal of Ethnopharmacology 282, pages 114581.
Crossref
Cong Xu, Yi-Ming Li, Bo Sun, Fang-Jing Zhong & Lian-Yue Yang. (2021) GNA14’s interaction with RACK1 inhibits hepatocellular carcinoma progression through reducing MAPK/JNK and PI3K/AKT signaling pathway. Carcinogenesis 42:11, pages 1357-1369.
Crossref
Fan Bao, Peiqi Hao, Su An, Yang Yang, Ying Liu, Qian Hao, Mubashir Ejaz, Xiao-Xi Guo & Tian-Rui Xu. (2021) Akt scaffold proteins: the key to controlling specificity of Akt signaling. American Journal of Physiology-Cell Physiology 321:3, pages C429-C442.
Crossref
Ya‐Ping Liu, Can‐Can Zheng, Yun‐Na Huang, Ming‐Liang He, Wen Wen Xu & Bin Li. (2021) Molecular mechanisms of chemo‐ and radiotherapy resistance and the potential implications for cancer treatment. MedComm 2:3, pages 315-340.
Crossref
Zhaohui Liu, Zheng Hu, Xingdong Cai & Shengming Liu. (2021) SLC39A5 promotes lung adenocarcinoma cell proliferation by activating PI3K/AKT signaling. Pathology - Research and Practice 224, pages 153541.
Crossref
Li Zhang, Heping Chen, Yueqiong Song, Qing Gu, Lu Zhang, Qin Xie, Jin Xu & Min Zhang. (2020) MiR-325 Promotes Oxaliplatin-Induced Cytotoxicity Against Colorectal Cancer Through the HSPA12B/PI3K/AKT/Bcl-2 Pathway. Digestive Diseases and Sciences 66:8, pages 2651-2660.
Crossref
ZAHRA NASRPOUR NAVAEI, GHAZALEH KHALILI-TANHA, AMIR SADRA ZANGOUEI, MOHAMMAD REZA ABBASZADEGAN & MEYSAM MOGHBELI. (2021) PI3K/AKT signaling pathway as a critical regulator of Cisplatin response in tumor cells. Oncology Research 29:4, pages 235-250.
Crossref
Antoaneta Trendafilova, Laila M. Moujir, Pedro M. C. Sousa & Ana M. L. Seca. (2020) Research Advances on Health Effects of Edible Artemisia Species and Some Sesquiterpene Lactones Constituents. Foods 10:1, pages 65.
Crossref
Wei-Jia Cheng, Ping-Ping Zhang, Qian-Qian Luo, Shi-Ming Deng & Ai-Qun Jia. (2020) The chemosensitizer ferulic acid enhances epirubicin-induced apoptosis in MDA-MB-231 cells. Journal of Functional Foods 73, pages 104130.
Crossref
Rui Liu, Youwen Chen, Guangzhi Liu, Chenxi Li, Yurong Song, Zhiwen Cao, Wen Li, Jinghong Hu, Cheng Lu & Yuanyan Liu. (2020) PI3K/AKT pathway as a key link modulates the multidrug resistance of cancers. Cell Death & Disease 11:9.
Crossref
Zhiliang Huang, Yu Gao & Dianchen Hou. (2020) Interleukin-22 enhances chemoresistance of lung adenocarcinoma cells to paclitaxel. Human Cell 33:3, pages 850-858.
Crossref
Hossein Javid, Jahanbakhsh Asadi, Farnaz Zahedi Avval, Amir R. Afshari & Seyed Isaac Hashemy. (2020) The role of substance P/neurokinin 1 receptor in the pathogenesis of esophageal squamous cell carcinoma through constitutively active PI3K/Akt/NF-κB signal transduction pathways. Molecular Biology Reports 47:3, pages 2253-2263.
Crossref
Yanling Fan, Weiyao Si, Wei Ji, Zhiyong Wang, Zicong Gao, Ran Tian, Weijie Song, He Zhang, Ruifang Niu & Fei Zhang. (2019) Rack1 mediates tyrosine phosphorylation of Anxa2 by Src and promotes invasion and metastasis in drug-resistant breast cancer cells. Breast Cancer Research 21:1.
Crossref
Zhiping Ren, Lin Chen, Yimeng Wang, Xinbing Wei, Shenglan Zeng, Yi Zheng, Chengjiang Gao & Huiqing Liu. (2019) Activation of the Omega-3 Fatty Acid Receptor GPR120 Protects against Focal Cerebral Ischemic Injury by Preventing Inflammation and Apoptosis in Mice. The Journal of Immunology 202:3, pages 747-759.
Crossref
Linlin Zhang, Ya Xu, Li Wang & Hong Liu. (2019) Role of RACK1 on cell proliferation, adhesion, and bortezomib-induced apoptosis in multiple myeloma. International Journal of Biological Macromolecules 121, pages 1077-1085.
Crossref
Qi Shi, Lu-Yan Shen, Bin Dong, Hao Fu, Xiao-Zheng Kang, Yong-Bo Yang, Liang Dai, Wan-Pu Yan, Hong-Chao Xiong, Zhen Liang & Ke-Neng Chen. (2018) The identification of the ATR inhibitor VE-822 as a therapeutic strategy for enhancing cisplatin chemosensitivity in esophageal squamous cell carcinoma. Cancer Letters 432, pages 56-68.
Crossref
Hui Shi, Yinting Mao, Qianqian Ju, Yingcheng Wu, Wen Bai, Peiwen Wang, Yudong Zhang & Maorong Jiang. (2018) C-terminal binding protein‑2 mediates cisplatin chemoresistance in esophageal cancer cells via the inhibition of apoptosis. International Journal of Oncology.
Crossref
Enrique Konstat-Korzenny, Jorge Ascencio-Aragón, Sebastian Niezen-Lugo & Rosalino Vázquez-López. (2018) Artemisinin and Its Synthetic Derivatives as a Possible Therapy for Cancer. Medical Sciences 6:1, pages 19.
Crossref